Analytical Data
-
基因名
ST1
- Application
-
别名
SDCBP; MDA9; SYCL; TACIP18; Syndecan Binding Protein; Scaffold protein Pbp1; Melanoma differentiation-associated protein 9; Pro-TGF-alpha cytoplasmic domain-interacting 18
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O00560
-
表达区间
Ser2~Val298
-
分子量
36kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ST1 recombinant protein has garnered significant attention in the field of biochemistry and molecular biology due to its potential applications in therapeutic and diagnostic processes. The protein, originally identified in specific strains of Streptococcus, plays a crucial role in various biological functions, including immune response modulation and cell signaling pathways. Researchers have focused on ST1 due to its unique structural properties and functional capabilities, which suggest it could serve as a valuable tool in drug development and vaccine formulation. Moreover, the ability to produce ST1 as a recombinant protein allows for high-yield and cost-effective manufacturing, facilitating extensive research into its mechanisms of action. Studies have demonstrated that ST1 interacts with multiple cellular targets, promoting further investigation into its implications for autoimmune diseases and infectious conditions. The ongoing exploration of ST1 recombinant protein offers promising insights into the development of novel therapeutics that can improve clinical outcomes across various medical challenges.
